Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| TB TippingPoint BiosciencesCompany profile Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer | $4.5M | Seed | Biotech | United States | Investors | |
| SO Standing OvationCompany profile Produces high-quality casein from whey permeates using precision fermentation Produces high-quality casein from whey permeates using precision fermentation | €30M | Series B | Biotech, Foodtech | France | Investors | |
| S Develops next-generation cell assay technology for drug discovery | $3.8M | Undisclosed | Biotech | United Kingdom | Investors | |
| O ONCOMATRYXCompany profile Develops Quantum ADCs against the tumor microenvironment for metastatic solid tumors Develops Quantum ADCs against the tumor microenvironment for metastatic solid tumors | $67M | Series B | Biotech | Spain | Investors | |
| C CentivaxCompany profile Develops vaccines and therapies for universal protection against diverse targets Develops vaccines and therapies for universal protection against diverse targets | $37M | Undisclosed | Biotech | United States | Investors | |
| MS Miraterra SoilCompany profile Develops high-fidelity soil measurement solutions using AI, genomics, and spectroscopy Develops high-fidelity soil measurement solutions using AI, genomics, and spectroscopy | CA$16M | Seed | Biotech, Agritech | Canada | Investors | |
| EB Epoch BiodesignCompany profile Develops enzymatic recycling technology to transform plastic waste into valuable resources Develops enzymatic recycling technology to transform plastic waste into valuable resources | $12M | StrategicUndisclosed | Biotech, Climate tech | United Kingdom | Investors | |
| R RenasensCompany profile Develops textile recycling technology using CO₂ to separate and decolour blended textiles Develops textile recycling technology using CO₂ to separate and decolour blended textiles | €10M | Seed | Biotech, Climate tech | Sweden | Investors | |
| CT Cellbricks TherapeuticsCompany profile Develops biofabricated human tissue implants and aims to manufacture 3D-printed organs Develops biofabricated human tissue implants and aims to manufacture 3D-printed organs | €10M | Seed+Non-DilutiveUndisclosed | Biotech | Germany | Investors | |
| CF Cauldron FermCompany profile Provides continuous hyper-fermentation technology for industrial-scale bio-production Provides continuous hyper-fermentation technology for industrial-scale bio-production | $13.3M | Series A2Series A | Biotech | Australia | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.